Home > Result Summaries: Compounds > naratriptan > Result Summary for S2WA1004

Result Summary for S2WA1004

Result Summary

Protocol ID:	S2WA1004
Clinical Study ID:	S2WA1004
Official Title:	A comparative study of the pharmacologic effects of naratriptan, codeine and placebo in experienced psychoactive substance users.
Phase:	Phase 1
Study Indications or Diseases:	Migraine Disorders
Generic Name:	naratriptan
Trade/Product Name:	amerge;naramig
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Abstract: Comparative abuse liability of codeine and naratriptan. Somer, Gail MD, Sellers, Edward M MD, Busto, U E PharmD, Kaplan, H L PhD, and Baylon, G J MD 99th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics 3/30/1998 (Location not available) special population, Fuseau E/ Cephalalgia 1997;17(3):409